Study of XL418 in Adults With Solid Tumors
The purpose of this study is to evaluate the safety and tolerability of XL418 in subjects with solid tumors. XL418 is a new chemical entity that inhibits a spectrum of targets, including Akt and p70S6K, that mediate PI3 Kinase / PTEN signaling.
Cancer|Solid Tumors
DRUG: XL418
Safety, tolerability, and maximum tolerated dose of XL418 with daily oral administration
Plasma pharmacokinetics and pharmacodynamic effects of daily oral administration of XL418
The purpose of this study is to evaluate the safety and tolerability of XL418 in subjects with solid tumors. XL418 is a new chemical entity that inhibits a spectrum of targets, including Akt and p70S6K, that mediate PI3 Kinase / PTEN signaling.